Coronavirus vaccine : Covaxin trials to enter Phase 3

In a new ray of hope in the Coronavirus vaccine development, Covaxin developed by AstraZeneca and Oxford University has successfully triggered a strong immune response.

Now, Covaxin has successfully entered phase 3 of trial.